E-mail
|
Department of Molecular & Cellular
Biology
Harvard University
16 Divinity Avenue
Cambridge, MA 02138
617 495-2906 (phone)
617 496-1354 (fax)
gelbart@morgan.harvard.edu
Faculty Positions
- Harvard University, Assistant Professor of Biology, 1976-1980.
- Harvard University, Associate Professor of Cellular and Developmental
Biology, 1980-1983.
- Harvard University, Professor of Molecular and Cellular Biology,
1983-present.
Educational Background
- Harpur College, SUNY, Binghamton, NY, 1962-1963
- Brooklyn College, CUNY, Brooklyn, NY, 1963-1966; B.S., Biology, 1966
- University of Wisconsin, Madison, WI, 1966-1971; Ph.D., Genetics,
1971
- Predoctoral fellow with Dr. Allen S. Fox.
- California Inst. Tech., Pasadena, CA, 1971-1972; Developmental
Genetics
- Postdoctoral fellow with Dr. Edward B. Lewis.
- University of Connecticut, Storrs, CT, 1972-1976; Genetics
- Postdoctoral fellow with Dr. Arthur Chovnick.
Current Major Departmental & University Activities
- Undergraduate and Predoctoral Education:
- Program Director, Interdepartmental Predoctoral Training Program in
Genetics & Genomics,
2000-present.
- Head Tutor, Biology Undergraduate Concentration, 1994-present. (Director
of the Biology Undergraduate Major in Biology)
Advisory
- Faculty Advisor, The Harvard Foundation, 1996-present. (Focal University
organization devoted to multicultura l understanding).
- Member, University Committee on Research Policy, 2001-present.
National Scientific Advisory Committees
NIH Panels:
- Member, NIH Genetic Basis of Disease (GBD) Training Grant Study Section,
1984-1988; Chair, 1987-1988.
- Ad Hoc Member, Advisory Council to the National Institute of
General Medical Sciences, 1/1989, 1/1994, 5/1996.
- Member, Human Genome Research Study Section, NIH, 1996-1999.
- Member, NHGRI Large-Scale Genome Sequencing Network Advisory
Committee, 1999-present (Advisory Committee to Francis
Collins, Director, NHGRI, on the human and model organism genome
sequencing projects)
- Member, National Advisory Council to the National Human
Genome Research Institute, Oct. 2000-2004.
- Chair, NHGRI Panel on Prioritization of New Genome Sequencing
Projects, 2001-present.
Bioinformatics & Database Advisory Panels:
- Member, Genome Resources Advisory Committee, National Center for
Biotechnology Information, National Library of Medicine, NIH, 1999-2000.
- Advisor, MGI - Mouse Genetics Informatics, Jackson Laboratories,
Bar Harbor, ME, 1998, 2002.
- Advisor, WormBase, California Insitutes of Technology (C.
elegans Genome and Genetic Database), 2001-present.
- Advisor, ZFIN - Zebrafish Genome and Genetic Database, U.
Oregon, 2001-present.
- Member, Board of Directors,New England Complex Systems Insitute,
Cambridge, MA, 1998-present.
American Cancer Society:
- Member, American Cancer Society Advisory Panel on Devel. Biology,
1992-1996.
- Ad Hoc Member, Extramural Advisory Council, American Cancer Society,
1999, 2001.
Consultant to Industry
- Consultant to Functional Genomics Therapeutic Area, Novartis Pharmaceuticals,
1999-present.
- Consultant to GeneLogic, Inc., 2000-2001.
Other Service and Honors
- Organizer, Fifty-fourth Annual Genetics Society of America Conference,
1985.
- Member, Board of Directors, Genetics Society of America, 1988-1990.
- Editor, Drosophila Information Service (volumes 69, 73, 74, 78,
79).
- Organizer, Thirty-third Annual Drosophila Research Conference, 1992.
- Fellow, American Association for the Advancement of Science, 1993.
- Recipient, NIH MERIT Award, 1995-2003.
- President, Drosophila Board of Directors, 1996-1997.
Research Program
Background: My long term interest has been in understanding the global
interactions by which the gene products encoded by the genome mediate
the cell-cell patterning events that underlie development. My laboratory
has studied cell-cell patterning for the last 15-20 years, with the main
emphasis on the identification and characterization of the gene products
involved in TGF-beta ligand signaling in Drosophila (for example, we
discovered decapentaplegic (dpp), the first member of the bone morphogenesis
subfamily of the TGF-beta protein superfamily, co-discovered the first
mutations in DPP receptors, and the discovered the Smad protein family,
the central proteins in TGF-beta signal transduction (encoded by the
Mothers against dpp (Mad) and Medea (Med) genes). Further, we have uncovered
and did much of the initial characterization of the many of the fundamental
patterning processes to which the DPP signaling pathway contributes and
first recognized that DPP is likely to act in embryonic dorsoventral
patterning and anteriori-posterior development of the adult appendage
precursors (the imaginal disks) as a secreted, concentration-dependent
morphogen. In addition to these studies, I have had a significant and
long-standing interest in an epigenetic phenomenon, termed transvection,
in which the expression of specific genes is modulated by the state of
organization of the interphase nucleus.
Current Research Efforts: One of the exciting opportunities of the last
few years has been to look at such problems globally through high-throughput
experimental approaches and by computational analysis. In order to effectively
carry out such analyses, it is crucial that there be a solid foundation
of information on the structure and function of the genome and its encoded
products. Building this foundation, especially in the major model system,
the fruit fly Drosophila melanogaster, has become the central issue for
my group for the last few years.
The finishing of the sequencing of the euchromatic portions of the D.
melanogaster genome occurred about a year ago. Even with this full, high
quality sequence to gaze at, understanding the nature of the products
encrypted within that sequence and of the encrypted regulatory elements
that control the deployment of those products remains challenging. Nonetheless,
attaching as much molecular biological and phenotypic information to
the genome’s sequences is of crucial importance to the success
of efforts in the “post-genomic” or “functional genomic” era.
Thus, my groups efforts are focused on several aspects of genome annotation.
Experimental Annotation of the Genome: Even in as well-studied a genetic
system as D. melanogaster, our ability to efficiently mutate every known
or predicted transcription unit in the genome is limited. We have developed
a novel tool consisting of a compound transposable element containing
two independent mobilization elements to aid in this process. Using this
P{wHy} system molecularly defined nested sets of deletions can be
generated bidirectionally from the insertion site of a single P{wHy}
element residing at any location in the genome. The resulting deletions
range in size from a few base pairs to several hundred kilobase pairs,
and are generated at high efficiency. Within 50 kb of the starting insertion
site, deletions can be generated with offset endpoints every kb or so,
meaning that the likelihood of separating any two transcription units
within 50 kb of a starting point is very high. We are saturating the
genome for P{wHy} insertion sites as starting points for generating such
deletions. (We estimate that already, 45% of the autosomal euchromatin
is within 50kb of one of our inserted elements.) We are adapting the
system for high throughput, and for use in such applications as (1) the
efficient identification of the transcription units associated with each
of about 1500-2000 anonymous recessive lethal/sterile complementation
units (2) the homozygous deletion of anonymous transcription units by
overlap of precisely-mapped deletions derived from P{wHy} elements bracketing
the gene of interest, (3) in vivo mapping of extended regulatory elements,
(4) high throughput preparation of RNAs for microarray/chip probes from
mutant individuals such as those described in (2).
Computational Annotation of the Genome -- Gene Predictions: With the
finishing of the euchromatic sequence of D. melanogaster, FlyBase has
the responsibility to capture and synthesize all pubished information
about the genome. (I am the PI of the FlyBase Consortium, with sites
at Harvard, Berkeley (Gerry Rubin, co-PI), Indiana (Thom Kaufman & Kathy
Matthews, co-PIs) and U. Cambridge (UK) (Michael Ashburner & Rachel
Drysdale, co-PIs). One major aspect of this is to develop and maintain
the authoritative predictions of the structures of all of the genes in
the genome. Toward this end, FlyBase has recently swept through the finished
sequence, producing a new canonical set of transcription unit structures
for the 13,380 protein-coding genes. The reannotation effort has included
use of experimental sequence data (cDNAs/ESTs), sequence similarity data,
and ab initio gene predicitions. We are now following this up with more
selective re-examination of the gene models based on newly available
cDNA sequences and on comparisons with the sequence of a second Drosophila
species -- Drosophila pseudoobscura -- and with two other insect genomes
-- the malarial mosquito, Anopheles gambiae and the honey bee, Apis mellifera.
Computational Annotation of the Genome -- DNA Motifs: We are developing
computer-assisted, interactive methods for identification of DNA motifs
corresponding to regulatory elements and other protein-binding sites
within the genome. Thus far, we have identified several different motifs
at/near transcription start sites, including one that has properties
suggestive of it being a novel initiator element. We are extending these
studies to explore computational techniques for identifying motifs located
remotely from transcription start sites. In addition, we are exploring
predictions of non-protein coding genes, using small nucleolar RNAs (sno-RNAs)
as a first testbed. We are complementing the computational studies with
functional experiments to explore the validity and roles of the sequences
thus identified.
Computational Analysis of the Genome -- Database Mining Techniques: FlyBase also captures a great deal of information of genes, alleles,
molecules and phenotypes using a variety of controlled, hierarchically
arranged vocabularies as well as free text. As part of our internal project,
and also in collaboration with computer scientists at MITRE, Inc., we
are continually exploring ways to mine information from data sets such
as ours, to achieve interoperability with other biological databases,
and to exploit natural language querying systems for the purposes of
automatic data capture and data mining.
Computational Analysis of the Genome -- Quantitation of Anatomical
Phenotype and Spatial Expression Patterns: While methods for analyzing molecules
in a highly automated, high throughput fashion are either available or
can be imagined, there is a pressing need for developing techniques to
phenotype individuals with equally high efficiency. We have a small research
project to develop such techniques and to apply these techniques to characterize
the anatomical patterns and spatial expression patterns of wild-type
and mutant individuals. |